RTI Surgical Launches Bone Graft Solutions

RTI Surgical announced it is launching two new bone grafting solutions at the American Academy of Orthopaedic Surgeons annual meeting in New Orleans — NanOss Bioactive 3D and map3 Cellular Allogeneic Bone Graft.

Advertisement

NanOss Bioactive 3D is a synthetic 3D bioscaffold which supports bone formation, and map3 Cellular Allogeneic Bone Graft is an implant that contains the elements needed to generate and maintain new bone. It is a natural alternative to autograft.

More Articles on Devices:

Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.